Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: A report of 2 cases

Clinical Neuropharmacology

Volumn 28, Issue 4, 2005, Pages 195-196

  Gourzis, Philippos ^a   Polychronopoulos, Panagiotis ^a   Papapetropoulos, Spiridon ^a   Assimakopoulos, Konstantinos ^a   Argyriou, Andreas A ^a   Beratis, Stavroula ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Antipsychotic treatment; Quetiapine; Tardive dystonia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; DYSTONIA; HEMATOLOGIC DISEASE; HUMAN; MALE; NEUROLOGIC EXAMINATION; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; TARDIVE DYSTONIA;

ADULT; ANTI-DYSKINESIA AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIBENZOTHIAZEPINES; DYSKINESIA, DRUG-INDUCED; HUMANS; MALE; RISPERIDONE; SCHIZOPHRENIA;

EID: 23644451497     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnf.0000174933.89758.c9     Document Type: Article

References (23)

1. Kiriakakis V, Bhatia KP, Quinn NP, et al. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain. 1998;121:2053-2066.
2. Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 1982;32:1335-1346.
3. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
4. Guy W, ed. ECDEU assessment manual for psychopharmacology. Publication ADM 76-338. Washington, DC: US Department of Health, Education and Welfare; 1976:534-537.
5. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord. 1986;1:193-208.
6. Tan E-K, Jankovic J. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry. 2000;68:186-190.
7. Raja M, Maisto G, Altavista MC, et al. Tardive lingual dystonia treated with clozapine. Mov Disord. 1996;11:585-586.
8. Shapleske J, Mickay AP, McKenna PJ. Successful treatment of tardive dystonia with clozapine and clonazepam. Br J Psychiatry. 1996;168:516-518.
9. Kasper S, Tauscher J, Heiden A. Quetiapine: efficacy and tolerability in schizophrenia. Eur Neuropsychopharmacol. 2001;11(suppl 4):S405-S413.
10. Kasper S, Muller-Spahn F. Review of quetiapine and its clinical applications in schizophrenia. Exp Opin Pharmacother. 2000;1:783-801.
11. Sasaki Y, Kusumi I, Koyama T. A case of tardive dystonia successfully managed with quetiapine. J Clin Psychiatry. 2004;65:583-584.
12. Flynn SW. Improvement of torticollis with quetiapine in a schizophrenia patient. Can J Psychiatry. 2004;49:152.
13. Nelson MW, Reynolds RR, Kelly DL, et al. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Clin Neuropharmacol. 2003;26:297-298.
14. Yoshida K, Higuchi H, Hishikawa Y. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient. Clin Neuropharmacol. 1998;21:68-69.
15. Armstrong L, Randal P. Spasmodic dysphonia: a rare form of tardive dystonia, induced by low-dose risperidone? Aust N Z J Psychiatry. 2004;38:174.
16. Charfi F, Cohen D, Houeto JL, et al. Tardive dystonia induced by atypical neuroleptics: a case report with olanzapine. J Child Adolesc Psychopharmacol. 2004;14:149-152.
17. Jonnalagada JR, Norton JW. Acute dystonia with quetiapine. Clin Neuropharmacol. 2000;23:229-230.
18. Saller CF, Salama AI. Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacology (Berl). 1993;112:285-292.
19. Kapur S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry. 1999;156:286-293.
20. Seeman P, Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry. 1999;156:876-8S4.
21. Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002;47:27-38.
22. 2 receptors explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry. 2001;158:360-369.
23. Adams RD, Victor M, eds. Principles of neurology. New York: McGraw-Hill; 1993.